Malaria (DBCOND0007188)

Identifiers

Synonyms
Plasmodium Infection / Plasmodium Infections / Infections, Plasmodia / Plasmodia infections / Malaria (disorder) / Malaria NOS / Disease due to Plasmodiidae (disorder) / Malaria, unspecified / Paludism / Unspecified malaria / Malarial fever (finding)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Acetyl sulfisoxazole
Acute, recurrent or chronic urinary tract infections (primarily pyelonephritis, pyelitis and cystitis) due to susceptible organisms (usually Escherichia coli, Klebsiella-Enterobacter, staphylococcus, Proteus mirabilis and, less frequently, Proteus vulgaris) in the...
Artemether
An antimalarial agent used in combination with lumefantrine for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.
Chloroquine
An antimalarial drug used to treat susceptible infections with P. vivax, P. malariae, P. ovale, and P. falciparum. It is also used for second line treatment for rheumatoid arthritis.
Hydroxychloroquine
An antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus.
Ivermectin
An anti parasite medication used to treat head lice, onchocerciasis, strongyloidiasis, ascariasis, trichuriasis, and enterobiasis.
Primaquine
An antimalarial indicated to prevent relapse of vivax malaria.
Sulfadoxine
A long acting sulfonamide used for the treatment or prevention of malaria.
Sulfametopyrazine
An antibiotic used in the treatment or prevention of bacterial infections and malaria.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05117567
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and CambodiaNo drug interventionspreventionNot Availableunknown_status
NCT00330902
Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudantreatment3completed
NCT02721186
Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in ZanzibarpreventionNot Availablecompleted
NCT03719599
Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, LiberiaNo drug interventionsNot AvailableNot Availablecompleted
NCT03931473
Efficacy of Two Dual Active Ingredient Long Lasting Insecticidal Nets for Control of Malaria Transmitted by Pyrethroid Resistant Vectors in BeninNo drug interventionspreventionNot Availablecompleted
NCT03937817
Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04323306
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.No drug interventionstreatment1completed
NCT04966702
Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)treatment3active_not_recruiting
NCT05652504
Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)No drug interventionsprevention1suspended
NCT05796193
Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote D'IvoireNo drug interventionspreventionNot Availableactive_not_recruiting
NCT06607003
Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding AssaysNo drug interventionsbasic_science1not_yet_recruiting
NCT00001645
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic InfectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT02471378
Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine CandidatesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02639299
Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria ChallengeNo drug interventionsNot AvailableNot Availablerecruiting
NCT05690841
FocaL Mass Drug Administration for Vivax Malaria EliminationNo drug interventionsprevention3not_yet_recruiting
NCT01168271
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, MaliNo drug interventionsNot AvailableNot Availablerecruiting
NCT03074435
Insecticide Resistance Management in Burkina Faso and Côte D'Ivoireprevention3completed
NCT03671109
Improving Maternal heAlth by Reducing Malaria in African HIV Womenprevention3completed
NCT05581641
Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against MalariaNo drug interventionsprevention1completed
NCT06141057
A Study to Compare Two Dosing Regimens for a New Malaria Vaccinetreatment1active_not_recruiting
NCT04650815
Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina FasoNo drug interventionsNot AvailableNot Availablecompleted
NCT04704674
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, LiberiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04969913
Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, GuineaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05400655
Anti-malaria MAb in Kenyan ChildrenNo drug interventionsprevention2completed
NCT05913973
Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adultsprevention1recruiting
NCT06069544
A Clinical Trial to Evaluate the Safety, Efficacy and Immune Responses After Vaccination with an Investigational RNA-based Vaccine Against MalariaNo drug interventionsprevention1 / 2recruiting
NCT06575647
Vivax Elimination With Tafenoquine (VET) Studytreatment4not_yet_recruiting
NCT06590597
Improving Knowledge, Attitudes and Practices for Malaria Prevention in the Embera Katio PopulationNo drug interventionstreatmentNot Availablecompleted
NCT01240603
Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00341003
Severe Malaria and Anti-malarial Drug Resistance in CambodiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00442403
Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malariatreatment3suspended
NCT01154803
Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With InfectionNo drug interventionspreventionNot Availablecompleted
NCT00131703
Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Womentreatment3completed
NCT05444790
Abbott NxTekTM Malaria RDT WHO Prequalification StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00740090
Malaria Vaccine for Children in Maliprevention1completed
NCT04148690
Assessing the Impact of Group Antenatal Care on IPTp Uptake in TanzaniaNo drug interventionshealth_services_researchNot Availableterminated
NCT00317590
Effectiveness and Cost-Effectiveness of a Rapid Diagnostic Test for MalariaNo drug interventionsdiagnostic4completed
NCT02315690
Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swazilandtreatment3completed
NCT04079621
Short Course Radical Cure of P. Vivax Malaria in Nepaltreatment4completed
NCT04069221
Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Studytreatment1completed
NCT00115921
Evaluation of Home-Based Management of Fever in Urban Ugandan ChildrenNo drug interventionstreatmentNot Availablecompleted
NCT03163121
Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch VolunteersNo drug interventionsprevention1completed
NCT01972321
ICCM of Common Childhood Diseases: Mozambique and UgandaNo drug interventionshealth_services_researchNot Availablecompleted
NCT05604521
A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMINo drug interventionsprevention1terminated
NCT02488902
A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparumtreatment2completed
NCT01190202
Epidemiology Study of Malaria Transmission Intensity in AfricaNo drug interventionsotherNot Availablecompleted
NCT01052584
Ethiopia Malaria Therapeutic Efficacy StudytreatmentNot Availablecompleted
NCT01703884
ANC & Malaria Diagnostic in PregnancyNo drug interventionsprevention4completed
NCT00669084
Innate and Acquired Resistance to Plasmodium Falciparum Malaria in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT02517879
Community Point Distribution of Insecticide Treated Bed NetsNo drug interventionspreventionNot Availablecompleted
NCT02528279
Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum MalariaotherNot Availablecompleted
NCT01373879
AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic AreaNo drug interventionsprevention1completed
NCT02900079
Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International TravelersNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01785979
Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegalytreatment3withdrawn
NCT00342043
Examination of Protective Factors Against Severe MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT00167843
Reducing the Effects of Malaria in Children by Administering Repeated Preventive Dosesprevention4completed
NCT01697787
Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Fasotreatment4completed
NCT00158587
Eight Week Primaquine Regimen for the Treatment of Vivax Malariatreatment3completed
NCT02083887
A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian InfantsNo drug interventionsprevention1completed
NCT04858087
Malawi International Center of Excellence in Malaria Research School-based CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT02013687
Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy AdultsNo drug interventionsprevention1completed
NCT00870987
Clinical Trial for Malaria Vaccines to Test for Safety, Immune Response and Protection Against Malariaprevention1 / 2completed
NCT05223933
Proactive Community Case Management (Pro-CCM) in Rural MadagascarNo drug interventionshealth_services_researchNot Availablecompleted
NCT02704533
Sequential Optimization of Dose and Schedule of PfSPZ VaccineNo drug interventionsprevention1completed
NCT02783833
MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part BNo drug interventionstreatment1 / 2completed
NCT06232954
Evaluation of the Protective Efficacy of a Spatial Repellent to Reduce Malaria Prevalence in UgandaNo drug interventionspreventionNot Availablerecruiting
NCT03967054
Repeat Ivermectin Mass Drug Administrations for MALaria Control IIprevention3active_not_recruiting
NCT01645254
Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in MaliNo drug interventionsNot Available1unknown_status
NCT01422954
Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxisbasic_scienceNot Availablecompleted
NCT01916954
Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancytreatment3completed
NCT05478954
Chemoprevention Efficacy Study in Burkina Fasoprevention4active_not_recruiting
NCT03341754
Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Malaria Infection in Malaria Naïve AdultsNo drug interventionsprevention1completed
NCT02511054
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...prevention1completed
NCT04494854
Perceptions, Representations and Experiences of Malaria Prophylaxis in Patients Born in Endemic Areas and Living in France.No drug interventionsNot AvailableNot Availablecompleted
NCT00469651
Phase Ib Trial of MSP3 LSP in Children in Tanzaniaprevention1unknown_status
NCT00808951
In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Fasotreatment4completed
NCT01603251
Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmissiontreatment1 / 2completed
NCT03217851
Prevalence Survey of Antimalarial Drug Resistance MarkersNo drug interventionsNot AvailableNot Availablecompleted
NCT01397851
Stimulating Private Sector Malaria ControlNo drug interventionshealth_services_researchNot Availablecompleted
NCT05084651
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazoletreatment1completed
NCT00217451
Treatment of Malaria in Gabon With Fosmidomycin-Clindamycintreatment2completed
NCT02511353
Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Studytreatment2completed
NCT06560853
Evaluation of a Comprehensive School Health Programme in ZambiaNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT05340153
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroontreatment4unknown_status
NCT04020653
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malariatreatment2withdrawn
NCT03707353
An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAPNo drug interventionsprevention1 / 2completed
NCT02758353
The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in NigeriaNo drug interventionshealth_services_researchNot Availablecompleted
NCT00367653
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.treatment3completed
NCT02199977
Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail SectorNo drug interventionshealth_services_researchNot Availablecompleted
NCT04370977
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)treatment4completed
NCT01585077
Exposure of Naive and Pre-immune Subjects to P. Vivax ChallengeNo drug interventionsbasic_science1 / 2completed
NCT00385047
A Study to Determine Whether 2 Investigational Malaria Vaccines Are Safe, Protective Against Malaria in AdultsNo drug interventionsprevention1 / 2completed
NCT03083847
Dose Escalation PfSPZ-CVacprevention1completed
NCT01635647
A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Fasoprevention1 / 2completed
NCT02927145
A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine CandidateNo drug interventionsprevention1 / 2completed
NCT01075945
Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudantreatment4unknown_status
NCT00119145
Kintampo Trial of Combination Therapy for Malariatreatment4completed
NCT02914145
Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern MozambiquetreatmentNot Availablecompleted
NCT02653898
Malaria Elimination Pilot Study in Military Forces in Cambodiaprevention4unknown_status
NCT00878098
Study of DDT and Loss of Clinically-Recognized Pregnancies in South AfricaNo drug interventionsNot AvailableNot Availablecompleted
NCT00374998
Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PPNo drug interventionsprevention1completed
NCT06166498
Parasite Clearance and Protection From Infection (PCPI) in Zambiaprevention3recruiting
NCT01958905
Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished ChildrentreatmentNot Availablecompleted
NCT06044805
Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivaxtreatment4completed
NCT03035305
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in MalipreventionNot Availablecompleted
NCT00878397
Impact of School-based Delivery of Long Lasting Insecticide NetsNo drug interventionspreventionNot Availablecompleted
NCT00341783
Assessment of Biologic Parameters in Preparation for Future Malaria Vaccine Trials in Don gu Bougou, MaliNo drug interventionsNot AvailableNot Availableterminated
NCT01862783
Collection of Biological Material From Pregnant Women in a Malarial RegionNo drug interventionsNot AvailableNot Availableterminated
NCT01364883
Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAPNo drug interventionsprevention1completed
NCT04230161
Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in RwandaNo drug interventionsNot AvailableNot Availablecompleted
NCT01624961
Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune AdultsNo drug interventionsdiagnostic1completed
NCT04235361
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCNo drug interventionsNot AvailableNot Availableunknown_status
NCT00132561
A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Childrenprevention2 / 3completed
NCT00454961
Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzaniatreatment4completed
NCT01728961
Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapytreatment4terminated
NCT04724161
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in MozambiqueNo drug interventionsNot AvailableNot Availablecompleted
NCT02118428
Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted MalariaNo drug interventionspreventionNot Availablecompleted
NCT02213211
School-based Programme of Malaria Diagnosis and Treatment in Southern MalawitreatmentNot Availablecompleted
NCT05304611
Anti-malaria MAb in Malian ChildrenNo drug interventionsprevention2completed
NCT00720811
Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTstreatmentNot Availablecompleted
NCT03970993
VAC 072-An Efficacy Study of R21/MM in Different Dose Schedulesprevention1 / 2completed
NCT05287893
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malariaother1completed
NCT01450293
AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic AreaNo drug interventionsprevention1completed
NCT02282293
Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)prevention3completed
NCT00565071
Parasite-based Diagnosis for Malaria in Uganda: Feasibility and Cost-EffectivenessNo drug interventionsdiagnosticNot Availableunknown_status
NCT01190371
Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment?treatment4unknown_status
NCT03483571
Dynamics of Subclinical Malaria: Preliminary StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00121771
Malaria Candidate Vaccines FP9 Circumsporozoite (CS) and MVA CS in Adult Gambian Menprevention1completed
NCT02151578
Home Management of Malaria and PneumoniaNo drug interventionstreatment4completed
NCT06318078
Buikwe Electronic Community Health Information System Impact StudyNo drug interventionshealth_services_researchNot Availablerecruiting
NCT00269178
Cluster Randomized Trial of Peer Health Education in Malaria in The GambiaNo drug interventionsother3completed
NCT02174978
Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve AdultsNo drug interventionsprevention1completed
NCT02492178
Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malariabasic_science2completed
NCT00336388
Use of Rapid Diagnostic Tests for Malaria Case Management in KenyaNo drug interventionsdiagnosticNot Availablecompleted
NCT02294188
Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - IndonesiaNo drug interventionspreventionNot Availablecompleted
NCT02181088
A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5No drug interventionsprevention1completed
NCT00935688
Examination of ACT Implementation in a Vivax / Falciparum Co-endemic AreaNo drug interventionsdiagnostic4completed
NCT00452907
ACT MALI: Treatment of Malaria Based on Combination Therapiestreatment4completed
NCT00436007
Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimenprevention2completed
NCT00878007
Impact of Malaria Prevention on Health and Education in Kenyan SchoolchildrenNo drug interventionstreatmentNot Availablecompleted
NCT00138307
Correlates of Protection in GhanaNo drug interventionsNot AvailableNot Availablecompleted
NCT04053907
P. Falciparum Infection Dynamics and Transmission to Inform EliminationNo drug interventionsdiagnosticNot Availableunknown_status
NCT02215707
A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of DosesNo drug interventionsprevention1completed
NCT01292707
A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria TestsNo drug interventionshealth_services_researchNot Availablecompleted
NCT00373607
Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Perutreatment3completed
NCT00118807
Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Childrentreatment3completed
NCT06555809
Evaluation of Artesunate in Infants Being Treated for Severe MalariaNot AvailableNot Availablenot_yet_recruiting
NCT01949909
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ibprevention1completed
NCT00120809
Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidaeprevention3completed
NCT00984256
Weekly Dosing of Malarone ® for Prevention of Malariaprevention2completed
NCT05041556
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria VaccineNo drug interventionsNot AvailableNot Availableunknown_status
NCT00811356
A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malariatreatment1terminated
NCT02940756
Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congotreatment4completed
NCT02742285
Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spotother4completed
NCT04558515
Automated Microscopy Evaluation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01545115
Study of the Environmental Factors Modulating Children Immune Response in Northern SenegalNo drug interventionsNot AvailableNot Availablecompleted
NCT03128515
Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areastreatment3completed
NCT01624337
Malaria Prevention CambodiapreventionNot Availableterminated
NCT03960632
Performance Evaluation of Malaria Plus RDTsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04206332
Trial to Evaluate CIS43LS in Healthy AdultsNo drug interventionsprevention1completed
NCT02392832
Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria IncidenceNo drug interventionsotherNot Availablecompleted
NCT05905432
Pan-Malaria Transmission-Blocking Vaccine AnAPN1No drug interventionsprevention1not_yet_recruiting
NCT06392152
Efficacy of Focal Primaquine Mass Administration for Eliminating Plasmodium Vivax Malaria in Northern MyanmartreatmentNot Availableactive_not_recruiting
NCT00123552
Longitudinal Antimalarial Combinations in Ugandatreatment3completed
NCT02043652
Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, BraziltreatmentNot Availablecompleted
NCT01350752
Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of MalariaNo drug interventionshealth_services_researchNot Availablecompleted
NCT01697852
The Combined Use of Indoor Residual Spraying (IRS) and Long-lasting Insecticidal Nets (LLINs) for Malaria PreventionNo drug interventionsprevention4unknown_status
NCT00144352
In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adultstreatment4completed
NCT04321252
Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjectsother1completed
NCT02174900
Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)treatment2 / 3completed
NCT00513500
Zambia Integrated Management of Malaria and Pneumonia Studyhealth_services_researchNot Availablecompleted
NCT00869700
Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adultstreatment4completed
NCT02610400
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in NamibiaNo drug interventionstreatment3completed
NCT01018459
Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina FasoNo drug interventionsprevention1completed
NCT00944359
Impact of Preventive and Therapeutic Zinc Supplementation Programs Among Young ChildrenNo drug interventionspreventionNot Availablecompleted
NCT02938975
Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria PreventionNo drug interventionsprevention3unknown_status
NCT02671175
Post-discharge Malaria Chemoprevention(PMC) Studyprevention3completed
NCT02600975
A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01BNo drug interventionsprevention1completed
NCT03695770
Evaluation of a New Malaria Control Strategy Amongst Gold Miners Working Illegally in French Guiana (Malakit)No drug interventionsotherNot Availablecompleted
NCT06300970
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberiatreatment4completed
NCT06516042
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopiaprevention3not_yet_recruiting
NCT00442442
Clinical Evaluation of Mosquito Coils to Control Malaria in ChinaNo drug interventionsprevention3unknown_status
NCT00259142
Acceptability and Cost Effectiveness of Home Based Management of Fever: Different StrategiestreatmentNot Availableterminated
NCT00772642
Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the WombNo drug interventionsNot AvailableNot Availablecompleted
NCT00292942
Study of the Safety of Intravenous Artesunatetreatment1completed
NCT02554799
A Study to Evaluate the Pharmacokinetics of Oral Formulations of MMV390048 Administered Fasted to Healthy VolunteersNo drug interventionsbasic_science1completed
NCT00977899
Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate VaccineNo drug interventionsprevention1withdrawn
NCT02242799
Dolutegravir Interactions With Artemisinin-based Combination Therapiestreatment1completed
NCT02708199
Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody KineticNo drug interventionsNot AvailableNot Availablecompleted
NCT02699099
Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.prevention3completed
NCT02885506
A FIH Study to Investigate the Safety, Tolerability and PK of P218No drug interventionstreatment1completed
NCT02083406
Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP)treatment1completed
NCT06173206
Parasite Clearance and Protection From Infection (PCPI) in Cameroonprevention3recruiting
NCT00444106
Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Functiontreatment4completed
NCT02903706
Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French GuianaNo drug interventionsNot AvailableNot Availablecompleted
NCT00739206
Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.No drug interventionstreatment2terminated
NCT00075049
Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent MalariaNo drug interventionsprevention1 / 2completed
NCT02532049
A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313No drug interventionsprevention1completed
NCT00414336
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malariaprevention1completed
NCT03824236
A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve AdultsNo drug interventionsprevention2completed
NCT02533336
The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural Tanzaniaprevention3terminated
NCT03689036
Transmission Dynamics of Residual and Re-emerging Malaria in the Amazon: Defining a Roadmap to Malaria EliminationNo drug interventionsNot AvailableNot Availableunknown_status
NCT02793336
Early Life Cohort in Papua Indonesia (ELIPI Study)No drug interventionsNot AvailableNot Availablecompleted
NCT02645513
Text Message Reminders to Health Workers on Malaria, Pneumonia, and Diarrhea Case Management in MalawiNo drug interventionshealth_services_researchNot Availablecompleted
NCT02810613
Leiden University Medical Center Mini Donor BankNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00351013
The Use of Homeopathic-Based Treatment Approaches to Reduce the Prevalence of Malaria in Depressed CommunitiesNo drug interventionsprevention4completed
NCT01816113
Phase Ia Study of ChAd63/MVA PvDBPNo drug interventionsprevention1completed
NCT00349713
FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Maliprevention1completed
NCT02996513
Assessing Model Parameters for Applying the Retinol Isotope Dilution (RID) MethodNo drug interventionsdiagnosticNot Availablecompleted
NCT01921413
Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT)No drug interventionsNot AvailableNot Availablecompleted
NCT03576313
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Eliminationprevention3completed
NCT05934318
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)No drug interventionspreventionNot Availablenot_yet_recruiting
NCT00489619
Safe Pregnancy by Infectious Disease ControlNo drug interventionsNot AvailableNot Availablecompleted
NCT02817919
Cohort Event Monitoring in Sub Saharan AfricaNo drug interventionsNot AvailableNot Availablecompleted
NCT05746819
An MRI Ancillary Study of a Malaria Fever InvestigationNo drug interventionsNot AvailableNot Availablecompleted
NCT01958619
Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteerstreatment1completed
NCT00890019
A Study of AdCh63 ME-TRAP Alone and With MVA ME-TRAPprevention1completed
NCT01669941
Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenyaprevention4completed
NCT02880241
MMV390048 POC in Patients With P. Vivax and P. Falciparum MalariaNo drug interventionstreatment2terminated
NCT05205941
MMV533 Plasmodium Falciparum Volunteer Infection StudyNo drug interventionstreatment1completed
NCT03707041
Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge ModelNo drug interventionsprevention1completed
NCT04570241
Mobilization at the Level of Schools on the Behavioral Change in Favor of the Fight Against Malaria in MbandjockNo drug interventionspreventionNot Availableunknown_status
NCT02858817
Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxisprevention1completed
NCT00169117
A Stitch in Time May Save Lives: Turning Poor Bednets Into Good OnesNo drug interventionspreventionNot Availablecompleted
NCT00238017
Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunatetreatment4unknown_status
NCT01743417
Computerized Cognitive Rehabilitation in Children After Severe MalariaNo drug interventionstreatmentNot Availablecompleted
NCT05317117
Evaluating the Clinical Performance and Usability of Novel Malaria RDTs in BrazilNo drug interventionsdiagnosticNot Availableunknown_status
NCT00126217
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccineprevention4terminated
NCT05426434
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancyprevention3active_not_recruiting
NCT04456634
Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrinetreatment1completed
NCT02963324
Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteersbasic_science1completed
NCT00258024
Control of Pregnancy Associated Malaria With Intermittent Preventive TreatmentNo drug interventionspreventionNot Availablecompleted
NCT03705624
P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)No drug interventionsdiagnosticNot Availablecompleted
NCT01651416
Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghanaprevention4completed
NCT01976416
Novel Use Of Hydroxyurea in an African Region With Malariatreatment3completed
NCT02482116
A Comparison of Diagnostic Approaches for Malaria and PneumoniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01065116
Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packstreatment3completed
NCT05567016
CHILD (Child Health and Infection With Low Density) MalariaNo drug interventionspreventionNot Availableactive_not_recruiting
NCT02601716
PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve AdultsNo drug interventionsprevention2completed
NCT00948896
Chemopreventive Therapy for Malaria in Ugandan Childrenprevention3completed
NCT02473796
Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCTNo drug interventionshealth_services_researchNot Availablecompleted
NCT00146796
A Randomised Trial of Rapid Diagnostic Tests in the Diagnosis of Malaria in TanzaniaNo drug interventionsdiagnostic4completed
NCT01043796
Evaluation of Insecticide Treated Nets and Wall Liners for the Prevention of MalariaNo drug interventionsprevention3completed
NCT01836458
A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfectiontreatment2completed
NCT02903758
Frequency and Distribution of Mixed Falciparum-vivax Infections in French GuianaNo drug interventionsNot AvailableNot Availablecompleted
NCT01456858
Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in EmergenciesNo drug interventionsprevention3completed
NCT00320658
Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvantprevention1completed
NCT00131235
Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birthprevention3active_not_recruiting
NCT05285735
Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their InfantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00527163
Role of Nitric Oxide in MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT01867463
Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccineprevention1completed
NCT01038063
Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Periodtreatment4unknown_status
NCT00984763
A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malariaprevention1 / 2completed
NCT01378286
Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malariatreatment3completed
NCT01605786
Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage)No drug interventionsprevention1 / 2unknown_status
NCT01024686
Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria VaccineNo drug interventionsprevention1 / 2terminated
NCT03641339
Defining Skin Immunity of a Bite of Key Insect Vectors in HumansNo drug interventionsbasic_scienceNot Availablecompleted
NCT00206739
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infantsprevention4completed
NCT00451139
Ototoxicity of Artemether / Lumefantrine (Coartem) and Other AntimalarialsNot Available4completed
NCT00167739
Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethaminetreatment4completed
NCT00261222
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Fasotreatment2completed
NCT02793622
Prevention of Malaria in HIV-uninfected Pregnant Women and Infantsprevention3completed
NCT01666925
Efficacy of Malaria Vaccines in Kenyan Adultsprevention2completed
NCT05050825
Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalNo drug interventionsdiagnosticNot Availableunknown_status
NCT01464125
Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adultstreatment2unknown_status
NCT01379430
Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic AreasNo drug interventionsprevention1completed
NCT06036030
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papuatreatment2completed
NCT05816330
L9LS MAb in Malian AdultsNo drug interventionsprevention2completed
NCT02450630
Assessing the Effect of Strengthening Referral of Sick Children From the Private Health Sector and Its Impact on Referral Uptake in Uganda.No drug interventionshealth_services_researchNot Availableunknown_status
NCT00682630
Bioequivalence Trial of Pyronaridine Artesunate To-be-marketed Tablet to the Clinical Trial Reference Tablettreatment1completed
NCT01232530
Pharmacovigilance for ACTs in AfricaNo drug interventionsNot AvailableNot Availablecompleted
NCT04704830
R21/Matrix-M in African Children Against Clinical Malariaprevention3active_not_recruiting
NCT02654730
Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambiatreatment2 / 3terminated
NCT01443130
Chloroquine for Malaria in Pregnancyprevention3completed
NCT01766830
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)No drug interventionsdiagnosticNot Availablecompleted
NCT01465048
Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and SyringeNo drug interventionsNot AvailableNot Availablecompleted
NCT02389348
A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265treatment1 / 2completed
NCT01319448
Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Diseaseprevention1 / 2completed
NCT01351948
Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909prevention1completed
NCT02544048
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian AdultsNo drug interventionsNot AvailableNot Availablecompleted
NCT00158548
ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistantreatment3completed
NCT01194557
Introducing Rapid Diagnostic Tests Into the Private Health SectorNo drug interventionsdiagnosticNot Availablecompleted
NCT05856357
Perennial Malaria Chemoprevention (PMC) in Côte d'IvoireNot AvailableNot Availablerecruiting
NCT00466557
Plasmodium Resistance in A. GambiaeNo drug interventionsNot AvailableNot Availablecompleted
NCT01389557
Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatratreatment4completed
NCT01878357
Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquinetreatment4completed
NCT00623857
Micronutrients and Child Health StudyNo drug interventionsprevention3completed
NCT00465257
Efficacy of Artesunate + Amodiaquine Four Years After Its Introduction in ZanzibarNot Available4suspended
NCT03009526
Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawiprevention3completed
NCT00471666
Medical Implications of Coinfection With Malaria and Filariasis ParasitesNo drug interventionsNot AvailableNot Availablecompleted
NCT00116766
Field Evaluation of Plant-based Mosquito ControlNo drug interventionsprevention2completed
NCT02458066
Trial to Compare Effectiveness of 2 Insecticides in Preventing MalariaNo drug interventionspreventionNot Availablecompleted
NCT04050566
Malaria Birth Cohort (MBC) in Agogo, GhanaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01936766
Optimal Fluid Management in Adult Severe MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT00137566
The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissautreatment4unknown_status
NCT01142765
Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAPNo drug interventionsprevention1 / 2completed
NCT05535465
Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural CommunitiesNo drug interventionshealth_services_researchNot Availableunknown_status
NCT00130065
The Effect of Folic Acid on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenyatreatment4completed
NCT05219565
Evaluating ATSBs for Malaria Reduction in KenyaNo drug interventionspreventionNot Availablecompleted
NCT02878265
The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian ChildrenNo drug interventionsprevention3completed
NCT01658774
Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School ChildrentreatmentNot Availablecompleted
NCT00712374
Evaluation of the Public Health Impact of Seasonal Intermittent Preventive Treatment (IPT) in Children in Senegalprevention4unknown_status
NCT00399074
Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemiaprevention3completed
NCT02389374
A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladeshtreatment4completed
NCT00290420
Prevention of P. Vivax Malaria During Pregnancy in Boliviaprevention4withdrawn
NCT02605720
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaignstreatment3completed
NCT02613520
Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and InfantsNo drug interventionsprevention1completed
NCT01899820
Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenyatreatment3unknown_status
NCT00297882
Artemisinin-Based Combination Therapy: Clinical Trials in Cameroontreatment3completed
NCT00538382
Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of CongoNot Available1completed
NCT05930782
Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers.No drug interventionsprevention1completed
NCT01955382
Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malariatreatment2completed
NCT01935882
Low Dose Primaquine for Clearance of Gametocytestreatment2 / 3completed
NCT00791531
Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteerstreatment1completed
NCT01810731
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenyaprevention2 / 3withdrawn
NCT01663831
Repellents as Added Control Measure to Long Lasting Insecticidal NetsNo drug interventionspreventionNot Availablecompleted
NCT01836731
Impact Evaluation of Community-Based Health Programs in RwandaNo drug interventionspreventionNot Availablecompleted
NCT00443131
Characterisation of the Immune Responses of 2 Experimental Malaria VaccinesNo drug interventionsprevention2completed
NCT03897673
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic AreasNo drug interventionspreventionNot Availableactive_not_recruiting
NCT02687373
Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in KenyaNo drug interventionsprevention1 / 2completed
NCT05330273
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenztreatment1completed
NCT03521973
Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese ChildrenNo drug interventionsprevention2completed
NCT00421473
Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patientsprevention4completed
NCT02590627
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failuretreatment4completed
NCT02313376
Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi MosquitoesNo drug interventionsbasic_science1completed
NCT00550160
The Synergistic Effects of Home-management and Intermittent Preventive Treatment of Malaria in Childrenhealth_services_research4completed
NCT00209794
IPTi in Mozambican Infants for Malaria Preventionprevention1 / 2unknown_status
NCT05788094
ACT vs CQ With Tafenoquine for P. Vivax Mono-infectiontreatment4recruiting
NCT04157894
Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina FasoNo drug interventionsNot AvailableNot Availablecompleted
NCT02411994
Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malariatreatment3completed
NCT03304691
Molecular Basis of Erythrocyte Invasion by Plasmodium Vivax Into Duffy-Negative Erythrocytes in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT03056391
Effect of Paracetamol on Renal Function in Plasmodium Knowlesi Malariatreatment3completed
NCT01843491
A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic ReagentsNo drug interventionshealth_services_research1withdrawn
NCT02015091
Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive AdultsNo drug interventionsprevention1completed
NCT02418962
Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean AdultsNo drug interventionsprevention1completed
NCT04788862
A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in TanzaniaNo drug interventionsotherNot Availablecompleted
NCT00285662
Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG InfantsNo drug interventionspreventionNot Availablecompleted
NCT01976780
In Vivo and In Vitro Efficacy of Artemisinin Combination Therapytreatment4completed
NCT00294580
Early Childhood Malaria Prevention With Maloprim in The GambiaNo drug interventionsprevention4completed
NCT00354380
Safety and Efficacy of Methylene Blue Combined With Artesunate or Amodiaquine for Malaria Treatment in Children of Burkina Faso: a Pilot Studytreatment2completed
NCT02387580
Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tabletstreatment1completed
NCT01500980
Malaria Challenge in Healthy Volunteersprevention1completed
NCT01231880
School Based Malaria Control in Ugandan Schoolchildrenprevention3completed
NCT05019729
Trial to Evaluate L9LS in Healthy AdultsNo drug interventionsprevention1completed
NCT00292929
Study of the Safety of Intravenous Artesunatetreatment1completed
NCT00125489
CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawitreatment4completed
NCT01080989
The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsNo drug interventionsscreeningNot Availablecompleted
NCT04336189
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Ugandaprevention3completed
NCT01156389
Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Studytreatment1completed
NCT02458092
Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01Bprevention1completed
NCT00146692
A Trial of Improved Financial Access to Healthcare in GhanaNo drug interventionstreatment4completed
NCT04102592
Getting Malaria "Off the Back" of Women and Children in Western UgandaNo drug interventionspreventionNot Availablecompleted
NCT04864444
Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination ActivitiespreventionNot Availablecompleted
NCT00424944
Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccineprevention1unknown_status
NCT05471544
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudanprevention3active_not_recruiting
NCT01228344
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT02298140
Providers' Compliance to Malaria TreatmentNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01210040
Long-term Iron Supplements and Malaria Risk in Early Pregnancy: a Randomized Controlled TrialNo drug interventionssupportive_careNot Availablecompleted
NCT01345240
Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)prevention3completed
NCT00944840
Intermittent Preventive Treatment (IPTc) and Home Based Management of Malaria (HMM)in The Gambiaprevention3completed
NCT00384267
Congenital and Neonatal Malaria in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT00215267
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, UgandatreatmentNot Availablecompleted
NCT00519467
Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malariatreatment2completed
NCT06386367
Health Education by Buddhist Monks to Promote Malaria Knowledge and Preventive Practices in Rural MyanmarNo drug interventionspreventionNot Availablecompleted
NCT00432367
Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancytreatment3completed
NCT05644067
Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Countryprevention1completed
NCT01290601
Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adultstreatment2terminated
NCT02329301
Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern ZambiatreatmentNot Availablecompleted
NCT01048801
Role and Effectiveness of Rapid Diagnostic Tests in Home-based Management of MalariaNo drug interventionstreatmentNot Availablecompleted
NCT01782001
Evaluation of Vitamin A and Zinc Supplementation on Malarial MorbidityNo drug interventionsprevention3completed
NCT05206201
A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjectstreatment1completed
NCT03304704
Community Dynamics of Malaria Transmission and Mosquito Feeding in Bancoumana, MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT04329104
Safety and Efficacy of CIS43LS Anti-malaria mAb in MaliNo drug interventionsprevention2completed
NCT01341704
Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africaprevention2completed
NCT02563704
A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroontreatment3completed
NCT06578572
Seasonal R21 Mass Vaccination for Malaria EliminationNo drug interventionsprevention3recruiting
NCT04315272
Gut and Azithromycin Mechanisms in Infants and Children IItreatment4completed
NCT01907672
The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community LevelNo drug interventionsdiagnostic4completed
NCT04978272
Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)prevention3active_not_recruiting
NCT00978068
HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Childrenprevention3completed
NCT05874869
Dihydroartemisinin-piperaquine for Seasonal Malaria Chemoprophylaxis in TanzaniapreventionNot Availablecompleted
NCT00346346
Analysis of the Immune Response to the Malaria Parasite in Mali, West AfricaNo drug interventionsNot AvailableNot Availablecompleted
NCT05348746
ERASE - Impact of COVID-19 on Malaria ControlNo drug interventionsNot AvailableNot Availableunknown_status
NCT00738946
A Trial of the Combined Impact of Intermittent Preventive Treatment and Insecticide Treated Bednets in Reducing Morbidity From Malaria in African ChildrenNo drug interventionspreventionNot Availablecompleted
NCT06040346
Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed With Plasmodium Falciparumtreatment2recruiting
NCT05400746
A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UKprevention0unknown_status
NCT01459146
Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghanaprevention4unknown_status
NCT00380146
Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant WomenpreventionNot Availablecompleted
NCT00663546
Malaria Studies in CambodiaNo drug interventionsNot AvailableNot Availablecompleted
NCT02119312
Malaria Clinical Trials Center General ScreeningNo drug interventionsNot AvailableNot Availablecompleted
NCT01119612
Prenatal Iron Supplements: Safety and Efficacy in TanzaniaNo drug interventionspreventionNot Availablecompleted
NCT02909712
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzaniabasic_science2completed
NCT01360112
Preventing the Spread of Malaria in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT01308112
Prenatal Iron and Malaria StudyNo drug interventionsprevention4completed
NCT03780712
Immune Dysfunction in Newborn SepsisNo drug interventionsNot AvailableNot Availablecompleted
NCT04566510
LLIN Evaluation in Uganda ProjectNo drug interventionspreventionNot Availablecompleted
NCT00298610
Safety and Efficacy Study of IV Artesunate to Treat Malariatreatment2completed
NCT05441410
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adultsprevention1 / 2not_yet_recruiting
NCT00114010
Experimental Vaccine for MalariaNo drug interventionstreatment1completed
NCT00540410
Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attackstreatment4completed
NCT04368910
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malariatreatment3terminated
NCT00790881
Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adultstreatment4completed
NCT06278181
Diabetes, Metabolic Syndrome and Risk of Malaria in CameroonNo drug interventionsNot AvailableNot Availablerecruiting
NCT01374581
Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malariatreatment3completed
NCT00687895
Improved Clinical and Microscopy Diagnosis at Primary Health Care in TanzaniaNo drug interventionshealth_services_research4completed
NCT01133314
Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2No drug interventionsNot AvailableNot Availablecompleted
NCT02294214
Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - TanzaniaNo drug interventionspreventionNot Availablewithdrawn
NCT00563914
A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated Malariatreatment1 / 2completed
NCT04601714
Baseline Cohort Malaria Morbidity StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02793414
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in EthiopiaNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03162614
Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve AdultsNo drug interventionsprevention2completed
NCT00203814
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated MalariatreatmentNot Availablecompleted
NCT00361114
IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.treatment3terminated
NCT01095055
A Study of AdCh63 AMA1 Alone and With MVA AMA1prevention1completed
NCT03199755
Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malariatreatment2withdrawn
NCT00376155
Comparison of Two Strategies for the Delivery of IPTcprevention4completed
NCT02431650
Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agenttreatment1 / 2completed
NCT02374450
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate VaccineNo drug interventionsNot AvailableNot Availablecompleted
NCT04666350
Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding AssaysNot AvailableNot Availablecompleted
NCT00341250
Malaria Vaccine in Children in MaliNo drug interventionstreatment1 / 2completed
NCT02831023
Phase 2 Efficacy Study of Primaquine and Methylene Bluetreatment2completed
NCT01713608
A Dose-escalation Study to Investigate Safety and Toleration of OZ439basic_science1completed
NCT00431808
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])No drug interventionsprevention1unknown_status
NCT00863408
Estivation of Malaria Vector Mosquitoes in the Sahelian Region of MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT02974608
Impact of Malaria on Pregnant Women in Ouelessebougou, MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT03278808
Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxistreatment2withdrawn
NCT02592408
A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the SudanNo drug interventionstreatment4completed
NCT01868438
Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteerstreatment1completed
NCT01445938
Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malariatreatment2terminated
NCT00214643
Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Childrentreatment3completed
NCT03352843
Single Low-dose Primaquine Efficacy and Safety.prevention4completed
NCT03874143
Clinical Evaluation of the Use of an mHealth Intervention on Quality of CareNo drug interventionshealth_services_researchNot Availablecompleted
NCT02925403
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvantprevention1 / 2completed
NCT00386503
Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditionstreatment1completed
NCT03916003
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areastreatment4completed
NCT01540903
Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian AdultsNo drug interventionsdiagnostic1completed
NCT00549003
Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in ZanzibarNo drug interventionsdiagnostic4completed
NCT01231503
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infantsprevention2completed
NCT02098590
Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous InfectionpreventionNot Availablecompleted
NCT01328990
Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)prevention1 / 2completed
NCT02788864
Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangersprevention4completed
NCT00327964
Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, UgandaNo drug interventionsNot AvailableNot Availablecompleted
NCT01614964
Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)treatment2completed
NCT01954264
Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan AfricaNo drug interventionsotherNot Availablecompleted
NCT00675064
Single-Blind, Placebo-Controlled, Randomized Study Testing Single Ascending Doses Of GSK369796 In Healthy SubjectsNo drug interventionsother1completed
NCT00811421
Evaluation of Alternative Antimalarial Drugs for Malaria in PregnancypreventionNot Availablecompleted
NCT00307021
Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese ChildrenNo drug interventionsprevention2completed
NCT05323721
Effectiveness and Chemoprevention Efficacy of Implementing Seasonal Malaria Chemoprevention in Karamoja Region, Ugandaprevention4active_not_recruiting
NCT01713621
OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observationtreatment2completed
NCT03203421
A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2No drug interventionsprevention1 / 2completed
NCT00917202
Efficacy of Methylene Blue for Malaria Treatment in Adults of Burkina Faso: Proof of Principle Study in Semi-Immune Adults of Burkina Faso in the Frame of the A8 Project of the SFB 544No drug interventionsNot Available2completed
NCT00719602
Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTtreatment0completed
NCT03989102
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in MaliNo drug interventionsprevention2completed
NCT04072302
Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Modelprevention1completed
NCT00471302
Normal Immunological Parameters Among Healthy Volunteers in Kambila, MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT02118402
Iron and Prebiotics Fortification in Kenyan InfantsNo drug interventionsbasic_scienceNot Availablecompleted
NCT02836002
Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1other1 / 2completed
NCT01523002
Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunatetreatment1completed
NCT01838902
Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carrierstreatment3completed
NCT00840502
Ultrasound Study in Pregnant Women With MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT00312702
Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of AmericaNo drug interventionsprevention1 / 2completed
NCT03594084
Malaria in Strasbourg University HospitalNo drug interventionsNot AvailableNot Availableunknown_status
NCT00372684
PALUREA: Severe Imported Malaria in AdultsNo drug interventionsNot AvailableNot Availablecompleted
NCT00422084
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patientstreatment3completed
NCT02230579
Phase I Study of Ascending Doses of MMV390048 in Healthy Adult VolunteersNo drug interventionstreatment1completed
NCT00393679
Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Childrentreatment3completed
NCT00938379
Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRprevention3unknown_status
NCT05155579
Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccinesprevention1active_not_recruiting
NCT00414479
Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of TreatmentNot AvailableNot Availablecompleted
NCT05736679
EaveTubes for Vector ControlNo drug interventionspreventionNot Availableactive_not_recruiting
NCT00510679
Study of Post-Training Supports for Health Workers in BeninNo drug interventionshealth_services_researchNot Availablecompleted
NCT03208179
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africaprevention3completed
NCT04766879
Spatial Repellents for the Prevention of Malaria in KenyaNo drug interventionspreventionNot Availablecompleted
NCT02898779
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1basic_science1completed
NCT04716387
Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in MozambiqueNo drug interventionsNot AvailableNot Availablecompleted
NCT05086887
Infections in Migrants in Sweden - the Importance of Malaria and Other Parasitic InfectionsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04002687
Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ)No drug interventionsprevention1completed
NCT04245033
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzaniaprevention4unknown_status
NCT01002833
Comparison of Three Plasmodium Falciparum Isolates in an Experimental Human Malaria InfectionNo drug interventionsbasic_scienceNot Availablecompleted
NCT00832754
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control TrialNo drug interventionstreatment4completed
NCT03917654
Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Maliprevention2completed
NCT03496454
Susceptibility of Gambian Adults to PfSPZ-Challenge Infection in the Controlled Human Malaria Infection ModelNo drug interventionsbasic_scienceNot Availablecompleted
NCT02199951
Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and TanzaniaNot AvailableNot Availableunknown_status
NCT01627951
Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria InfectionNo drug interventionsbasic_scienceNot Availablecompleted
NCT02206451
Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT02658253
Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adultsprevention1completed
NCT03420053
Study to Evaluate Safety, Immunogenicity and Efficacy of PfSPZ Vaccine in HIV Negative and HIV Positive Tanzanian AdultsNo drug interventionsprevention1completed
NCT02297477
The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodiatreatment4unknown_status
NCT00465777
Improved Management and in-Hospital MortalityNo drug interventionshealth_services_researchNot Availablecompleted
NCT00857077
Intermittent Preventive Treatment for Malaria in Infants in Navrongo GhanapreventionNot Availablecompleted
NCT02942277
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Maliprevention1completed
NCT04672577
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and MalariaNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02163447
Reducing the Burden of Malaria in HIV-uninfected Pregnant Women and Infantsprevention3completed
NCT03334747
Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.treatment2completed
NCT04238845
Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and MalnutritionNo drug interventionspreventionNot Availableunknown_status
NCT01449045
Trial of Malaria Seasonal IPTc Combined With Community Case Managementprevention3completed
NCT00127998
Antimalarial Drug Resistance in MalitreatmentNot Availablecompleted
NCT04545905
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina FasoNo drug interventionsNot AvailableNot Availablecompleted
NCT02527005
A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patientsprevention1completed
NCT04241705
Evaluation of Targeted Mass Drug Administration for Malaria in EthiopiaNo drug interventionspreventionNot Availableunknown_status
NCT02866097
Integrated Community Case Management Study in Eastern Province, ZambiaNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01157897
Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve AdultsNo drug interventionsprevention1 / 2completed
NCT02394197
Effectiveness of Malaria Treatment in Mexicotreatment4completed
NCT06225297
Evaluation of a Package of Interventions to Reduce the Burden of Malaria in the Urban Daaras of Touba, SenegalNo drug interventionsprevention4active_not_recruiting
NCT05958797
TES of Chloroquine for Pv in the Philippines in 2016Not AvailableNot Availablecompleted
NCT04695197
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Fasotreatment3completed
NCT01902797
Malaria Survey in the Tak Province Refugee CampsNo drug interventionsdiagnosticNot Availablecompleted
NCT00146783
Navrongo Drug Options for IPT in Pregnancy Trialprevention2 / 3completed
NCT01002183
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunatetreatment2withdrawn
NCT04816461
Boosting the Impact of SMC Through Simultaneous Screening and Treatment of Roommatesprevention4unknown_status
NCT00308061
Safety Study of Candidate Malaria Vaccine FMP1/AS02A in Healthy Adults in Bandiagara, Maliprevention1completed
NCT00158561
Chlorproguanil/Dapsone Compared With Chloroquine and SP for Vivax MalariaNot Available3completed
NCT02461628
Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector (Aim 2)No drug interventionshealth_services_researchNot Availablecompleted
NCT00197028
Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Regionprevention2completed
NCT04558528
Innovation PlatformNo drug interventionsNot AvailableNot Availablecompleted
NCT02672228
Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)No drug interventionsdiagnosticNot Availablecompleted
NCT00375128
Sporozoite Challenge of Polyprotein VaccineesNo drug interventionsprevention1 / 2completed
NCT00380393
Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.prevention2completed
NCT04966871
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve AdultsNo drug interventionsprevention1completed
NCT00497471
RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian InfantspreventionNot Availableterminated
NCT00126971
Chlorproguanil-Dapsone in Pregnant Womentreatment1suspended
NCT00852371
Intermittent Preventive Treatment of Malaria in Schoolchildrenprevention3completed
NCT00169078
Impact of Insecticide-treated Curtains on Antimalarial Drug ResistancetreatmentNot Availablecompleted
NCT00461578
Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan ChildrentreatmentNot Availablecompleted
NCT03512678
Evaluation of a Digital Microscope for MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT01205178
G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)basic_science1completed
NCT05123378
Liberia National Community Health Assistant (NCHA) Program and Under-five MortalityNo drug interventionspreventionNot Availableunknown_status
NCT01115478
Malaria in Pregnancy: Nutrition and Immunologic EffectsNo drug interventionspreventionNot Availablecompleted
NCT04222088
TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014Not AvailableNot Availablecompleted
NCT02793388
A Trial on Supervised Primaquine Use in Ethiopiatreatment4withdrawn
NCT00452088
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Fasoprevention1unknown_status
NCT02572388
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1prevention1completed
NCT00844207
A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquinehealth_services_research1completed
NCT04428307
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - KenyaNo drug interventionshealth_services_researchNot Availablecompleted
NCT01265407
Malaria Surveillance in Rakai, UgandaNo drug interventionsNot AvailableNot Availablecompleted
NCT05979207
Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. FalciparumNo drug interventionstreatment1completed
NCT02800109
Child Follow-up Until 2 YearsNo drug interventionsNot AvailableNot Availablecompleted
NCT01383109
Human Mass Balance Study of Pyronaridinetreatment1completed
NCT01160809
Effect of a Combined Use of Mosquito Repellent and Insecticide Treated Net on Malaria in EthiopiaNo drug interventionsprevention4completed
NCT02627456
Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Maliprevention1completed
NCT00453856
Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Childrentreatment4terminated
NCT00871156
Tafenoquine/Chloroquine DDI Studyother1completed
NCT00941785
Dihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina Fasoprevention2 / 3completed
NCT00541385
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patientstreatment3completed
NCT01717885
Antimalarial Pharmacology in Children and Pregnant Women in UgandaNo drug interventionsNot AvailableNot Availablecompleted
NCT04428385
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - NigeriaNo drug interventionshealth_services_researchNot Availablecompleted
NCT05058885
Plasmodium Vivax Among Duffy Negative Population in Cameroon.No drug interventionsNot AvailableNot Availablerecruiting
NCT00289185
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infantsprevention2completed
NCT04228315
Biomarkers of P. Vivax RelapsetreatmentNot Availablerecruiting
NCT02009215
School-Based Treatment With ACT to Reduce Transmissionprevention4completed
NCT01166815
Zinc Supplementation to Reduce Diarrhea Rates in Adults in Western Kenya.No drug interventionsprevention2 / 3completed
NCT05978037
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccinesprevention1 / 2recruiting
NCT00243737
Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malariatreatment2completed
NCT06529237
Malaria Molecular Surveillance in Mozambique (Phase 2)No drug interventionsNot AvailableNot Availablerecruiting
NCT02288637
Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray ProductNo drug interventionspreventionNot Availablecompleted
NCT02431637
Experimental Falciparum Transmission to AnophelesNo drug interventionstreatment1completed
NCT01805232
Intravenous Artesunate and Malariatreatment4unknown_status
NCT00119132
Effectiveness of Intermittent Preventive Treatment for Malaria in Childrenprevention2 / 3completed
NCT00680732
Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Componentprevention4completed
NCT06179732
Field Evaluations of Innovative Tools for Vector-borne Disease Control in Conflict-affected Communitiesprevention3completed
NCT00522132
Phase II Artesunate Study in Severe Malariatreatment2completed
NCT03224052
Empirical ANtibiotic THErapy in Adults Hospitalised With MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT01454752
Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and CognitionNo drug interventionspreventionNot Availablecompleted
NCT05889052
Perennial Malaria Chemoprevention (PMC) in CameroonNot AvailableNot Availablerecruiting
NCT00231452
Age of Exposure and Immunity to Malaria in InfantsNot AvailableNot Availablecompleted
NCT00287300
Efficacy and Safety of Azithromycin and Artesunate in Pregnant WomenpreventionNot Availablecompleted
NCT02878200
RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria TransmissiontreatmentNot Availablecompleted
NCT00527800
Interactions Between HIV and Malaria in African Childrentreatment3completed
NCT04839900
Proactive Community Case Management for Malaria in ZambiaNo drug interventionstreatmentNot Availablecompleted
NCT06225700
Clinical Validation of Novel Malaria Diagnostic Tools for POC Point-of-Care TestingNo drug interventionsNot AvailableNot Availablecompleted
NCT01148459
Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Childrenprevention3completed
NCT05286359
Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of MalariaNo drug interventionsdiagnosticNot Availablecompleted
NCT01755559
Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Nigertreatment4completed
NCT01853475
Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted Statetreatment1completed
NCT00323375
Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquinebasic_science1completed
NCT00229775
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the PhilippinestreatmentNot Availablecompleted
NCT00652275
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccineprevention2unknown_status
NCT00336375
Treatment of Uncomplicated Childhood Malaria in Tanzania by Artemether+Lumefantrine - Efficacy and Genotypingtreatment4completed
NCT04478370
Characterizing Humoral Immune Response to Mosquito BitesNo drug interventionsbasic_scienceNot Availablerecruiting
NCT02556242
Targeted Indoor Residual Spraying Against MalariaNo drug interventionsprevention4completed
NCT05946642
Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Fasoprevention3recruiting
NCT06122142
Spatial Repellents for Malaria ControlNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00440999
Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malariatreatment3completed
NCT02414399
Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Childrentreatment4active_not_recruiting
NCT01023399
Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoiretreatment4completed
NCT00561899
Comparison of Three Drug Combinations for Intermittent Treatment of Malaria in Childrenprevention2 / 3completed
NCT04844099
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemiaprevention3completed
NCT00716599
Training in Fever Case Management With Rapid Diagnostic Tests (RDTs) for Malaria in UgandaNo drug interventionsdiagnosticNot Availablecompleted
NCT02132299
Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian AdultsNo drug interventionsprevention1completed
NCT02491606
Evaluation of Weekly Tafenoquinetreatment2completed
NCT00397449
GMZ2-Aluminum Hydroxide Phase I, TübingenNo drug interventionsprevention1unknown_status
NCT03542149
Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQPother1completed
NCT05891236
Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy AdultsNo drug interventionsprevention1recruiting
NCT00203736
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated MalariatreatmentNot Availablecompleted
NCT01988636
Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African AdultsNo drug interventionsprevention1completed
NCT05072613
Monitoring Pregnant Women for Antimalarial Drug ResistanceNo drug interventionsNot AvailableNot Availablecompleted
NCT01084213
Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancyhealth_services_research4completed
NCT01575613
Reducing the Burden of Malaria by Targeting Hotspots of Malaria TransmissionpreventionNot Availablecompleted
NCT04778813
Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)treatment4unknown_status
NCT00347113
Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniapreventionNot Availablecompleted
NCT01082718
Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infectiontreatment2 / 3withdrawn
NCT00146718
Anti-Malarial Drug Resistance in Cameroontreatment2 / 3completed
NCT03399318
Aggressive Antipyretics for Fever Reduction in CNS Malariatreatment2completed
NCT02504918
Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT04897919
Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malariatreatment4completed
NCT02905019
A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAPprevention1 / 2completed
NCT06468319
Pregnancy Registry in MaliNo drug interventionsNot AvailableNot Availablerecruiting
NCT00866619
Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africaprevention3completed
NCT04622241
Uganda Housing Modification StudyNo drug interventionspreventionNot Availableunknown_status
NCT00197041
A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.No drug interventionsprevention2completed
NCT01082341
Immunization of Human Volunteers With P. Vivax Irradiated SporozoitesNo drug interventionsprevention1 / 2completed
NCT01524341
Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectiontreatment2completed
NCT01086917
Experimental Human Malaria Infection by PfSPZNo drug interventionsNot Available1completed
NCT04529434
Star Homes Project 2No drug interventionspreventionNot Availablerecruiting
NCT02910934
Cost-effectiveness Evaluation of Vector Control Strategies in MozambiqueNo drug interventionshealth_services_researchNot Availablecompleted
NCT01722734
Preserving ACTs - Text Reminders to Increase Adherence to ACT TreatmentNo drug interventionssupportive_careNot Availablecompleted
NCT03641534
Monitoring of Perfusion in Sepsis and MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT00329134
Investigation of the Efficacy of Quinine Sulphate Administered Via Taste-Masked Pellets to Children With Falciparum Malariatreatment2completed
NCT01366534
Safety, Immunogenicity and Efficacy Against of a Combined Malaria Vaccine in Healthy Malaria-naïve AdultsNo drug interventionsprevention2completed
NCT02561624
Hati Salama (Secure Voucher)No drug interventionspreventionNot Availablecompleted
NCT00544024
Mefloquine Bioequivalence Among 3 Commercially Available Tablets.No drug interventionsNot AvailableNot Availablecompleted
NCT02741024
Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congotreatment4completed
NCT00356824
Relationship Between HIV and Malaria in Ugandan ChildrenNot AvailableNot Availablecompleted
NCT02115516
Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under ChemoprophylaxisNo drug interventionsprevention1completed
NCT00487916
Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium FalciparumNo drug interventionsprevention1completed
NCT00144716
Evaluation of Combined Use of ITN's and Insect Repellents Against MalariaNo drug interventionsdiagnostic3completed
NCT00889616
Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and Maliprevention1completed
NCT03554616
Efficacy of Three Novel Bi-treated Long Lasting Insecticidal NetsNo drug interventionspreventionNot Availablecompleted
NCT02207816
An Extension to Study MALARIA-055 PRI (NCT00866619) to Evaluate the Long-term Efficacy, Safety and Immunogenicity of GSK Biologicals' Candidate Malaria Vaccine in Infants and Children in Africaprevention3completed
NCT04862416
Safety and Efficacy of R0.6C VaccineNo drug interventionsprevention1completed
NCT00445796
Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLerancetreatment4completed
NCT01658696
Efficacy of Candidate Malaria Vaccines in Senegalese Adultsprevention2completed
NCT03599596
Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamineprevention1unknown_status
NCT02153996
Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United StatesNo drug interventionsNot AvailableNot Availableterminated
NCT05979896
Chemoprevention Efficacy Study Nigeriaprevention4recruiting
NCT04708496
Optimizing Malaria Treatment for HIV-Malaria Co-infected Individualstreatment4unknown_status
NCT01256658
A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)treatment4completed
NCT00819858
Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on WeightNo drug interventionspreventionNot Availablecompleted
NCT00266058
Drug Interaction Study Between Antimalarial and Anti-HIV MedicationsNot Available1completed
NCT03503058
Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malariaprevention2recruiting
NCT06472258
Efficacy of Only IV Artesunate Versus IV Artesunate Plus IV Quinine in the Treatment of Severe Malaria in Children: A Comparative StudytreatmentNot Availablecompleted
NCT05354258
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African ChildrenpreventionNot Availableunknown_status
NCT00274235
Intermittent Preventive Treatment During Pregnancy in Beninprevention3completed
NCT00545935
Safety and Efficacy of Methylene Blue Combined With Amodiaquine or Artesunate for Malaria Treatment in Children of Burkina Fasotreatment2completed
NCT02739763
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)No drug interventionsbasic_science1unknown_status
NCT01027663
Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium FalciparumNo drug interventionsbasic_scienceNot Availablecompleted
NCT02692963
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infectionbasic_science2completed
NCT00386763
Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.treatment3completed
NCT00872963
An Extended Follow up of a RTS,S/AS01E Malaria Vaccine TrialNot AvailableNot Availableunknown_status
NCT00111163
Intermittent Preventive Treatment With Antimalarials in Kenyan InfantspreventionNot Availablecompleted
NCT00425763
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum MalariaNo drug interventionsprevention4completed
NCT05186363
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Studyprevention4active_not_recruiting
NCT02237586
Effect of Plasmodium Falciparum Exposure and Sickle Cell Trait on Infection Rates and Kinetics After IV Administration of PfSPZ ChallengeNo drug interventionsbasic_science1completed
NCT01939886
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)treatment3completed
NCT04695886
Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in MyanmarNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01062386
Malaria Survey in Mbarara District, Uganda 2010No drug interventionsNot AvailableNot Availablecompleted
NCT03432039
Preventing Mental Health Problems After Childhood Severe MalariaNo drug interventionspreventionNot Availablecompleted
NCT02394522
Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)No drug interventionspreventionNot Availablewithdrawn
NCT00120822
Folic Acid Supplementation in Gambian Primigravidaeprevention3completed
NCT03754322
LAMP Detection of Malaria in PREGnancy (LAMPREG) TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT01615822
Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteerstreatment1terminated
NCT00493922
Trial of Rapid Diagnostic Tests in Rural GhanaNo drug interventionsdiagnostic4completed
NCT00323622
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccineprevention2completed
NCT02536222
Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère DistrictsNo drug interventionsNot Available4completed
NCT00355225
Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina FasoNo drug interventionseducational_counseling_trainingNot Availablecompleted
NCT05605925
Ivermectin-artemisinin Combination Therapy for Eradication of Malariaprevention4recruiting
NCT01994525
Immunization Via Mosquito Bite With Radiation-attenuated SporozoitesNo drug interventionsprevention1completed
NCT00914225
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in KenyaNo drug interventionsNot AvailableNot Availablecompleted
NCT00378625
Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in ColombiaNot Available3completed
NCT01976325
Evaluating the Ottawa Malaria Decision AidNo drug interventionspreventionNot Availableunknown_status
NCT05391230
Permethrin-treated Baby-wraps for the Prevention of Malaria in ChildrenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT04940130
PfSPZ Vaccine Trial in Malian ChildrenNo drug interventionsprevention2completed
NCT01517230
Can Mass Media Campaigns Reduce Child MortalityNo drug interventionsNot AvailableNot Availablecompleted
NCT05236530
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravirtreatment1completed
NCT00360230
Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Childrenprevention2completed
NCT06155448
Perennial Malaria Chemoprevention (PMC) Effect StudyNo drug interventionspreventionNot Availableactive_not_recruiting
NCT04795648
Spatial Repellents for Vector ControlNo drug interventionspreventionNot Availablecompleted
NCT00132548
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Childrenprevention3completed
NCT01054248
Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancytreatment3completed
NCT00168948
Intermittent Antimalaria Treatment With SP in African Childrenprevention4unknown_status
NCT02698748
Evaluating the Role of Chloroquine for Malaria Eliminationprevention2 / 3completed
NCT01771848
Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune AdultsNo drug interventionsdiagnostic1completed
NCT00137657
Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistanceeducational_counseling_training4completed
NCT02573857
A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infectiontreatment1 / 2terminated
NCT05149157
Trajectories and Mechanisms of Recovery From Malaria: An Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02259426
Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmissiontreatment3completed
NCT02080026
Target Antigens Induced by Plasmodium Falciparum Sporozoite Immunization Under Chemoprophylaxisbasic_scienceNot Availablecompleted
NCT01024426
Impact of Enhanced Health Facility Care in UgandaNo drug interventionshealth_services_research4completed
NCT06461026
L9LS MAb in Malian InfantsNo drug interventionsprevention1recruiting
NCT02659566
Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT04944966
Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malariatreatment2completed
NCT05878366
Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)No drug interventionsotherNot Availablerecruiting
NCT00341666
Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesNo drug interventionsNot AvailableNot Availablecompleted
NCT00703066
Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Yearsprevention1unknown_status
NCT00673166
Evaluation of Local Mechanisms for Staff Motivation to Reduce Hospital MortalityNo drug interventionshealth_services_researchNot Availablecompleted
NCT01002066
Effectiveness Of Rapid Diagnostic Tests in the New Context of Low Malaria Endemicity in ZanzibarNo drug interventionsNot AvailableNot Availablecompleted
NCT04419766
Evaluation of IR3535 as a Spatial Repellent for Malaria Control.No drug interventionspreventionNot Availableactive_not_recruiting
NCT04167566
Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among ChildrenscreeningNot Availablecompleted
NCT01652365
Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail SectorNo drug interventionshealth_services_researchNot Availablecompleted
NCT01540474
Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adultstreatment1completed
NCT02694874
Rosiglitazone Adjunctive Therapy for Severe Malaria in ChildrentreatmentNot Availablecompleted
NCT03906474
VAC063C: A Study to Assess Repeat Blood-stage P. Falciparum InfectionNo drug interventionsotherNot Availablecompleted
NCT00158574
Kilimanjaro IPTi Drug Options Trialdiagnostic2 / 3completed
NCT02783820
Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part ANo drug interventionstreatment1completed
NCT00761020
Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria InfectionotherNot Availablecompleted
NCT00529620
Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegalprevention3completed
NCT01743820
Phase2a Primaquine Dose Escalation Studytreatment2completed
NCT05070520
Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sitestreatment4completed
NCT00699920
Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attackstreatment4completed
NCT02721420
Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in Malawiprevention3unknown_status
NCT01196520
Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)No drug interventionsNot AvailableNot Availablecompleted
NCT03523182
Spirulina Supplementation and Infant Growth, Morbidity and Motor DevelopmentNo drug interventionstreatmentNot Availablecompleted
NCT01152931
Antioxidant Micronutrients in Malariatreatment3completed
NCT00146731
A Trial of Antimalarial Drugs Used in Pregnancy in Tanzaniatreatment3completed
NCT00993031
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Womenprevention3completed
NCT01082731
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Braziltreatment4terminated
NCT01858831
Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspensionother1completed
NCT01809873
Sustainable Financial Incentives To Improve Prescription Practices For MalariaNo drug interventionshealth_services_researchNot Availablecompleted
NCT02661373
First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitorother1completed
NCT00639873
Artemisinin Resistance in BangladeshtreatmentNot Availablecompleted
NCT04265573
Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination TherapiesNo drug interventionsNot AvailableNot Availablecompleted
NCT04041973
Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)preventionNot Availablecompleted
NCT01425073
Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaNo drug interventionstreatmentNot Availablecompleted
NCT04094727
Malaria High-Risk Populations in Namibiatreatment4completed
NCT01397227
A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge ModelNo drug interventionsprevention1 / 2completed
NCT00118027
A New Approach to Deliver Malaria Preventions to Pregnant Women at a Community Level in UgandapreventionNot Availablecompleted
NCT01214876
Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen RepertoiresNo drug interventionsNot AvailableNot Availablecompleted
NCT00499876
The Effect of Malaria on Disease Progression of HIV/AIDSsupportive_careNot Availablecompleted
NCT06182176
Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth ControlpreventionNot Availablenot_yet_recruiting
NCT00890760
A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasitesprevention1 / 2completed
NCT03436160
Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine CompoundsNo drug interventionsdiagnostic0completed
NCT00455494
Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarialtreatment1completed
NCT00694694
Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.treatment3completed
NCT00131794
Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malariaprevention3completed
NCT00118794
Lapdap and Coartemether for Uncomplicated Malariatreatment3completed
NCT02894294
Evaluation of Seasonal Malaria Chemoprevention in KitaNo drug interventionsNot AvailableNot Availablecompleted
NCT05950191
LLIN Evaluation in Uganda Project (LLINEUP3)No drug interventionspreventionNot Availablerecruiting
NCT00964691
A Randomized Controlled Trial for Intermittent Preventive Treatment in Pregnancy With Fansidar in Solomon Islandsprevention4terminated
NCT03281291
An Ancillary Study Protocol to GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age"No drug interventionsNot AvailableNot Availablecompleted
NCT03276962
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Ageprevention2completed
NCT06153862
Africa Ready Malaria ScreeningNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02334462
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Maliprevention1completed
NCT03490162
Safety and Pharmacokinetics Study of DM1157 to Treat Malariatreatment1terminated
NCT00766662
Intermittent Preventive Treatment in Infant in Malihealth_services_researchNot Availablecompleted
NCT01280162
Malaria Active Epidemiology and Treatment StudytreatmentNot Availablecompleted
NCT01450280
Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CSNo drug interventionsprevention1completed
NCT00367380
Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human VolunteersNo drug interventionsbasic_science2completed
NCT02374580
Partnership and Dignity: a Mixed-methods Survey on Supporting and Retaining Uganda's Village Health TeamsNo drug interventionsNot AvailableNot Availablecompleted
NCT00666380
A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in KenyaNo drug interventionsprevention1completed
NCT02211729
A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Childrenprevention3completed
NCT00316329
ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malariatreatment3completed
NCT02072629
HCU: Can VHVs Trained in ICCM Improve Care for ChildrenNo drug interventionshealth_services_researchNot Availablecompleted
NCT03084289
A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of AdministrationNo drug interventionsprevention1completed
NCT01546389
Sanaria™ PfSPZ Challenge VaccineNot Available1completed
NCT01157689
Artemether-Lumefantrine Effectiveness in Guinea-BissauNo drug interventionsNot AvailableNot Availablecompleted
NCT01641289
Paracetamol Effect on Oxidative Stress and Renal Function in Severe MalariatreatmentNot Availablecompleted
NCT00697892
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinationstreatment1completed
NCT01837992
Safety and Efficacy of Primaquine for P. VivaxtreatmentNot Availableunknown_status
NCT01043744
Non-malarial Febrile Illness in Children in Areas of Perennial Malaria TransmissiontreatmentNot Availablecompleted
NCT03568344
Community Access to Rectal Artesunate for MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT01150344
Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malariatreatment4completed
NCT05085340
MULTIple Doses of IPTi Proposal: a Lifesaving High Yield InterventionNot AvailableNot Availablerecruiting
NCT03590340
Regimen Optimization Trial of PfSPZ Vaccine in Equatorial GuineaNo drug interventionsprevention1completed
NCT00197067
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.No drug interventionsother1completed
NCT05306067
Plasmodium Falciparum Genomic Intelligence in MozambiqueNo drug interventionsNot AvailableNot Availablecompleted
NCT01441167
Experimental PfSPZ Vaccine in Adults Without MalariaNo drug interventionsprevention1completed
NCT00427167
Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccineprevention1completed
NCT02600767
Artemether-lumefantrine for Treatment of P. Falciparum Malaria in BraziltreatmentNot Availablecompleted
NCT02535767
Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Malitreatment1 / 2completed
NCT03996967
Diagnostic and Prognostic Biomarkers for Childhood Bacterial PneumoniaNo drug interventionsNot AvailableNot Availablecompleted
NCT01754701
Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe MalariaNo drug interventionstreatmentNot Availablecompleted
NCT05085301
RapiGEN BIOCREDIT Malaria Ag RDTs WHO Prequalification StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02294201
Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - KenyaNo drug interventionspreventionNot Availablewithdrawn
NCT00203801
Combination Antimalarials in Uncomplicated MalariatreatmentNot Availablecompleted
NCT01728701
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisNo drug interventionsprevention1completed
NCT01845701
Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroontreatment3completed
NCT01511601
Apheresis to Obtain Plasma and White Blood Cells in MaliesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02251704
Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan AfricaNo drug interventionsother4completed
NCT05218304
Baromètre Santé Adulte 2021-2022No drug interventionsotherNot Availablesuspended
NCT03384472
Malaria Genetic Surveillance in CambodiaNo drug interventionsNot AvailableNot Availablecompleted
NCT05095272
Blood-Stage Plasmodium Vivax Cell BankNo drug interventionsother1completed
NCT01165372
Study of Malaria Treatment at Phuoc Long Hospital, Binh Phuoc Province, Vietnamtreatment2completed
NCT01323972
Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in ChildrenNo drug interventionsprevention3completed
NCT02932072
Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)No drug interventionsNot AvailableNot Availablecompleted
NCT01967472
Adherence to Antimalarial Drugs in Sierra LeonetreatmentNot Availablecompleted
NCT00978172
Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malariatreatment4completed
NCT00408668
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimenprevention1 / 2completed
NCT00225368
Effects of Insecticide Treated Bednets on Child Morbidity and MortalityNo drug interventionspreventionNot Availablecompleted
NCT02083068
Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivaxbasic_science2completed
NCT02168569
In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Childrentreatment4completed
NCT00451269
Evaluation of Rapid Diagnosis Tests in Imported MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT03963869
Effectiveness of Malaria Camps as Part of the Odisha State Malaria Elimination DriveNo drug interventionsotherNot Availablecompleted
NCT01857869
Efficacy, Safety and Immunogenicity Study of GlaxoSmithKline(GSK) Biologicals' Candidate Malaria Vaccine 257049 in the Sporozoite Challenge Model in Healthy Malaria-naïve AdultsNo drug interventionsprevention2completed
NCT01361269
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malariatreatment2unknown_status
NCT00913146
Can Treatment of Malaria be Restricted to Parasitologically Confirmed Malaria?No drug interventionsNot AvailableNot Availablecompleted
NCT05343312
In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambiquetreatment4active_not_recruiting
NCT01669512
Adjuvanting Viral Vectored Malaria Vaccines With Matrix Mprevention1completed
NCT06294912
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)treatment1recruiting
NCT02654912
Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug AdministrationNo drug interventionstreatment4completed
NCT06257810
Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaNo drug interventionsdiagnostic4completed
NCT04660110
Household-level Impact of IPT of Malaria in Schoolchildrenprevention3unknown_status
NCT02646410
Optimization of Seasonal Malaria Chemoprevention (SMC) DeliveryNo drug interventionspreventionNot Availableunknown_status
NCT05385510
Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIVprevention1active_not_recruiting
NCT00368810
Study of Factors Involved in Resistance to Severe MalariaNo drug interventionsNot AvailableNot Availablecompleted
NCT00190281
Contrast-Enhanced US of Spleen, Liver and KidneyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00853281
A Cluster Randomized Trial to Evaluate Long Lasting Insecticidal Hammocks to Prevent Forest Malaria in VietnamNo drug interventionspreventionNot Availablecompleted
NCT03510481
Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Maliprevention1completed
NCT01322581
A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in MaliNo drug interventionsNot AvailableNot Availablecompleted
NCT02509481
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Studytreatment2 / 3completed
NCT02453581
Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteerstreatment1completed
NCT01434381
Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)No drug interventionsprevention1completed
NCT02640495
Artemisinin Resistance In Malaria Treated With IV ArtesunateNot AvailableNot Availablewithdrawn
NCT03855995
A Study to Evaluate the Safety, Effectiveness and Impact of the GlaxoSmithKline Biologicals' Malaria Vaccine- RTS, S/AS01E in Young Children in Sub-Saharan AfricaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01392014
Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Casesprevention4completed
NCT03810014
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1No drug interventionshealth_services_researchNot Availablecompleted
NCT01003314
A Study of the Safety and Effectiveness of Two New Malaria VaccinesNo drug interventionsprevention1 / 2completed
NCT01130155
IMPACT2: Monitoring Interventions to Improve Artemisinin-based Combination Therapy (ACT) Access and TargetingNo drug interventionsNot AvailableNot Availableunknown_status
NCT04105855
Malaria Prevalence Around Maferinyah, GuineaNo drug interventionsNot AvailableNot Availablecompleted
NCT04800055
Attractive Targeted Sugar Bait Phase III Trial in ZambiaNo drug interventionspreventionNot Availableactive_not_recruiting
NCT01555255
Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental MalariaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00623155
Seasonal Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine in Children in MalipreventionNot Availablecompleted
NCT00850655
Genetic Association Mapping of Malaria Resistance in Anopheles GambiaeNo drug interventionsNot AvailableNot Availablecompleted
NCT00164255
Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancyprevention4completed
NCT03934450
Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers Receiving a Seven Day Dose Regimenbasic_science1completed
NCT01403350
Cluster Randomised Trial of Malaria RDTs Used by CHWs in AfghanistanNo drug interventionsdiagnostic4completed
NCT02859350
Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.prevention1completed
NCT03952650
Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...other1 / 2completed
NCT02149550
Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum StrainsNo drug interventionsbasic_scienceNot Availablecompleted
NCT00386750
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Functiontreatment4terminated
NCT01814423
Pharmacokinetic Study of Multi-dose Chloroquinetreatment4completed
NCT02052323
Harmonized AS/MQ Efficacy Study - Thailandtreatment4completed
NCT00121823
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria VaccinesNo drug interventionsprevention1 / 2completed
NCT01753323
Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infectiontreatment2completed
NCT04618523
Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congotreatment4completed
NCT00331708
Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With MalariatreatmentNot Availableterminated
NCT00495508
Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancytreatment4completed
NCT02094508
Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in UgandaNo drug interventionsNot AvailableNot Availablecompleted
NCT01704508
Improving Anti-malarial Treatment Options in Guinea-Bissau - Part Atreatment4completed
NCT01464138
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Childrentreatment2completed
NCT00873938
Compliance to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural GhanaNo drug interventionsNot AvailableNot Availablecompleted
NCT02698774
Low Resource Diagnostics Development Cohort - VZNIGHTNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02575755
A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Womenprevention4unknown_status